Kai M. Hildner

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis.

The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis.

Journal: Gut

Published: November 21, 2025

Coordinated Interferon-γ/Tumor Necrosis Factor Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel Diseases.

Coordinated Interferon-γ/Tumor Necrosis Factor Axis Drives Selective Loss of Activated Enteric Glia in Inflammatory Bowel Diseases.

Journal: Cellular and molecular gastroenterology and hepatology

Published: June 03, 2025

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Journal: Blood

Published: March 28, 2025

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.

Journal: Blood

Published: March 28, 2025

GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s.

GM-CSF and specific type 2 cytokines induce CD103+ and CD301b+ cell states in cDC1s and cDC2s.

Journal: Cell reports

Published: February 10, 2025

Dietary ω-3 polyunsaturated fatty acids (PUFAs) reduce cholesterol-driven non-small cell lung cancer (NSCLC) progression in mouse models of disease.

Dietary ω-3 polyunsaturated fatty acids (PUFAs) reduce cholesterol-driven non-small cell lung cancer (NSCLC) progression in mouse models of disease.

Journal: Communications medicine

Published: February 05, 2025

Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease.

Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease.

Journal: Science translational medicine

Published: January 15, 2025

The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.

The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.

Journal: Nature communications

Published: November 19, 2024

Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model.

Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model.

Journal: Transplantation and cellular therapy

Published: October 18, 2024

Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD.

Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD.

Journal: Gut

Published: August 26, 2024

Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors.

Metallophilic marginal zone macrophages cross-prime CD8+ T cell-mediated protective immunity against blood-borne tumors.

Journal: Immunity

Published: April 27, 2024

Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease.

Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease.

Journal: Frontiers in immunology

Published: July 05, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026